Your browser doesn't support javascript.
loading
Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy.
Garcia Garrido, Hannah M; Schnyder, Jenny L; Haydari, Beheshta; Vollaard, Albert M; Tanck, Michael W T; de Bree, Godelieve J; Meek, Bob; Grobusch, Martin P; Goorhuis, Abraham.
Afiliación
  • Garcia Garrido HM; Amsterdam UMC, Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands. Electronic address: h.m.garciagarrido@amsterdamumc.nl.
  • Schnyder JL; Amsterdam UMC, Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
  • Haydari B; Amsterdam UMC, Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
  • Vollaard AM; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Tanck MWT; Amsterdam UMC, Department of Epidemiology and Data Science, University of Amsterdam, Amsterdam, the Netherlands.
  • de Bree GJ; Amsterdam UMC, Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
  • Meek B; St Antonius Hospital, Department of Medical Microbiology and Immunology, Nieuwegein, the Netherlands.
  • Grobusch MP; Amsterdam UMC, Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
  • Goorhuis A; Amsterdam UMC, Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Int J Antimicrob Agents ; 60(2): 106629, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35760223
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Infecciones por VIH / Vacunas Neumococicas / Inmunogenicidad Vacunal Tipo de estudio: Observational_studies Idioma: En Revista: Int J Antimicrob Agents Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Infecciones por VIH / Vacunas Neumococicas / Inmunogenicidad Vacunal Tipo de estudio: Observational_studies Idioma: En Revista: Int J Antimicrob Agents Año: 2022 Tipo del documento: Article